Literature DB >> 10428936

Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.

M Müller1, M Brunner, U Hollenstein, C Joukhadar, R Schmid, E Minar, H Ehringer, H G Eichler.   

Abstract

Interstitial ciprofloxacin concentrations were measured by microdialysis in inflamed foot lesions of non-insulin-dependent diabetes mellitus patients following intravenous administration of 0. 2 g of ciprofloxacin. Interstitial ciprofloxacin concentrations were significantly lower than corresponding serum concentrations. There was no significant difference in the penetration of ciprofloxacin into inflamed and unaffected tissue (area under the concentration-time curve(infection)/area under the concentration-time curve(unaffected tissue) = 0.99 +/- 0.15 [mean +/- standard error], n = 6). Thus, inflammation appears to have little or no effect on the penetration of ciprofloxacin into tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428936      PMCID: PMC89414     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Treatment of skin and soft tissue infections with oral ciprofloxacin.

Authors:  R J Fass
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

2.  A microdialysis method allowing characterization of intercellular water space in humans.

Authors:  P Lönnroth; P A Jansson; U Smith
Journal:  Am J Physiol       Date:  1987-08

3.  General discussion on occlusive arterial disease in diabetes mellitus.

Authors:  N A Lassen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1973

Review 4.  The use of antibiotic serum levels to predict concentrations in tissues.

Authors:  D M Ryan; O Cars; B Hoffstedt
Journal:  Scand J Infect Dis       Date:  1986

5.  Tissue penetration and metabolism of ciprofloxacin.

Authors:  R Wise; I A Donovan
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Comparison of serum and tissue antibiotic levels in diabetes-related foot infections.

Authors:  G R Seabrook; C E Edmiston; D D Schmitt; C Krepel; D F Bandyk; J B Towne
Journal:  Surgery       Date:  1991-10       Impact factor: 3.982

7.  Effect of protein binding on antibiotic activity in vivo.

Authors:  D J Merrikin; J Briant; G N Rolinson
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

8.  Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.

Authors:  C M Licitra; R G Brooks; B E Sieger
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

9.  Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both.

Authors:  L R Peterson; L M Lissack; K Canter; C E Fasching; C Clabots; D N Gerding
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

10.  Clinical experience with ciprofloxacin in the USA.

Authors:  G Arcieri; R August; N Becker; C Doyle; E Griffith; G Gruenwaldt; A Heyd; B O'Brien
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

View more
  15 in total

1.  Target site concentrations of ciprofloxacin after single intravenous and oral doses.

Authors:  Martin Brunner; Heino Stabeta; Jan-Georg Möller; Claudia Schrolnberger; Boban Erovic; Ursula Hollenstein; Markus Zeitlinger; Hans Georg Eichler; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Perioperative penetration of metronidazole into muscle tissue: a microdialysis study.

Authors:  Juri Karjagin; Rein Pähkla; Joel Starkopf
Journal:  Eur J Clin Pharmacol       Date:  2003-10-29       Impact factor: 2.953

Review 3.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue.

Authors:  Christian Joukhadar; Pejman Dehghanyar; Friederike Traunmüller; Robert Sauermann; Bernhard Mayer-Helm; Apostolos Georgopoulos; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.

Authors:  F J Legat; R Krause; P Zenahlik; C Hoffmann; S Scholz; W Salmhofer; J Tscherpel; T Tscherpel; H Kerl; P Dittrich
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 7.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia.

Authors:  T B Jonsson; T K Nilsson; L H Breimer; J Schneede; B Arfvidsson; L Norgren
Journal:  Eur J Clin Pharmacol       Date:  2014-05-27       Impact factor: 2.953

9.  Tissue pharmacokinetics of levofloxacin in human soft tissue infections.

Authors:  Romuald Bellmann; Gerald Kuchling; Pejman Dehghanyar; Markus Zeitlinger; Erich Minar; Bernhard X Mayer; Markus Müller; Christian Joukhadar
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

10.  [18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans.

Authors:  Martin Brunner; Oliver Langer; Georg Dobrozemsky; Ulrich Müller; Markus Zeitlinger; Markus Mitterhauser; Wolfgang Wadsak; Robert Dudczak; Kurt Kletter; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.